In addition, given the important role of tumor suppressor p53 in endometrial cancer etiology, we assessed the impact of the p53 mutational status on OR5H2 regulation by using cell lines expressing a wild-type or a mutant p53. This evidence concerns the gene TP53 and endometrial cancer.